FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090980 [Registered on: 16/07/2025] Trial Registered Prospectively
Last Modified On: 15/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Medicinal paste application in scorpion bite. 
Scientific Title of Study   A Clinical Study To Evaluate The Efficacy of Jeerakadi Lepa in Vrishchika Damsha. 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shreya Sachin Chougule 
Designation  PG Scholar 
Affiliation  K V G Ayurveda Medical College and Hospital sullia 
Address  Room no 3 Agadatantra OPD K V G Ayurveda Medical College and Hospital Ambate adka Sullia Dakshina Kannada District Karnataka State

Dakshina Kannada
KARNATAKA
574239
India 
Phone  7676122645  
Fax    
Email  shreyasc1408@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Leeladhara DV  
Designation  Principal K V G Ayurveda Medical College and Hospital 
Affiliation  K V G Ayurveda Medical College and Hospital Sullia 
Address  Room no 3 Agadatantra OPD K V G Ayurveda Medical College and Hospital Ambate adka Sullia Dakshina Kannada District Karnataka State

Dakshina Kannada
KARNATAKA
574239
India 
Phone  7353756060  
Fax    
Email  drleeladhara_dv@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Leeladhara DV  
Designation  Principal K V G Ayurveda Medical College and Hospital 
Affiliation  K V G Ayurveda Medical College and Hospital Sullia 
Address  Room no 3 Agadatantra OPD K V G Ayurveda Medical College and Hospital Ambate adka Sullia Dakshina Kannada District Karnataka State

Dakshina Kannada
KARNATAKA
574239
India 
Phone  7353756060  
Fax    
Email  drleeladhara_dv@rediffmail.com  
 
Source of Monetary or Material Support  
K V G Ayurveda Medical College and hospital Ambate adka,sullia Dakshina Kannada,Karnataka, India Pin : 574327  
 
Primary Sponsor  
Name  Shreya Sachin Chougule 
Address  K V G Ayurveda Medical College and Hospital Sullia 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shreya Sachin Chougule   K V VG Ayurveda Medical College and Hospital Sullia  room no 3 agadatantra OPD K V G Ayurveda medical college sullia
Dakshina Kannada
KARNATAKA 
7676122645

shreyasc1408@gmail.com  
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:T632||Toxic effect of venom of scorpion. Ayurveda Condition: VRUSCIKAVISHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Jeerakadi lepa, Reference: Bhavaprakash Nigantu, Route: Topical, Dosage Form: Lepa Churna, Dose: 50(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients irrespective of sex , religion , socio-economic status having age between 16-65 years.
2.Patients with history of scorpion sting. 
 
ExclusionCriteria 
Details  1.Patients below age of 16 years of age.
2.Patients suffering from other systemic diseases that interfere with prognosis and management of scorpion sting.
3.Patients who have undergone any other treatment for same complaint.
4.Patients with other toxic bites.
5.Patients of vrishchika visha with asadhya lakshana.
6.Pregnant and lactating women. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessing the following symptoms of vrishchika damsha such as Daha, Ruk, Toda, Sphota  2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
remission of symptoms like daha, ruk, toda & sphota  1 week 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   26/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="15" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   ayurveda is one of renowned traditional systems of medicine. It deals with maintaining the health of healthy individuals and curing the disease of patients. 
among ashtanga, agadatantra stands separate in its concept, clinical approach, management and result.
according to source of origin visha is divided into two types i.e, sthavara and Jangama. Among Jangama Visha, Keeta Visha forms the major category due to the wide variety of species and their distribution pattern. Vrischika is considered among keeta visha.
Daha, Toda, Ruk and Kandu are the main symptoms of Vrischika damsha. 

Jeerakadi lepa is one of the formulations mentioned in Bhavapraksha which has significant effect on above mentioned symptoms. 

Jeerakadi lepa is administered externally to 30 patients presented with symptoms of vrischika damsha and assessment is done on 3rd and 8th day of the treatment. 
 
Close